AACE MENA 2025-Menopause and Cardiometabolic Risk

Video Transcription

Video Summary

The talk highlights that cardiovascular disease (CVD) is the leading cause of death in women, often presenting with more severe symptoms and poorer outcomes compared to men. Menopause, whether natural, premature, early, or surgical, increases women's cardiovascular risk due to hormonal changes affecting blood pressure, lipid profiles, insulin resistance, and body fat distribution. Symptoms like vasomotor disturbances, sleep issues, and depression further elevate risk. Accurate menopause prediction is challenging but important due to associated health implications. Prevention and treatment focus on lifestyle interventions—regular exercise, healthy diet, stress reduction, and smoking cessation—combined with monitoring and managing hypertension, dyslipidemia, and diabetes. Hormone therapy initiated early in menopause may offer cardiovascular benefits, but timing and individual risks must be considered. Emphasis is placed on education, early risk recognition, and personalized care to empower women and improve cardiovascular outcomes during midlife transitions.

Keywords

cardiovascular disease

menopause

hormonal changes

cardiovascular risk

lifestyle interventions

hormone therapy